Stoke Therapeutics, Inc 10-K for FY2023
Stoke Therapeutics, Inc. (STOK)
10-K
2024-03-25
For: 2023-12-31
View Original
Added on
April 08, 2026
About this 10-K
Stoke Therapeutics, Inc filed this 10-K on March 25, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.78M
- down 29.2% from $12.41M a year earlier
- Net loss
- $104.7M
- compared with a net loss of $101.07M a year earlier
- Diluted EPS
- -$2.38
- compared with -$2.60 a year earlier